Apolipoprotein E Polymorphism in a French Canadian Population of Northeastern Quebec: Allele Frequencies and Effects on Blood Lipid and Lipoprotein Levels

Human Biology

Volumn 68, Issue 3, 1996, Pages 357-370

  Robitaille, N ^a   Cormier, G ^a,d   Couture, R ^b   Bouthillier, D ^c   Davignon, J ^c   Perusse L ^a,d  

^a UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^b Hôtel Dieu de Roberval Hosp   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

Apolipoprotein E; Lipoproteins; Polymorphism

Indexed keywords

APOLIPOPROTEIN A; LIPID; LIPOPROTEIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLELE; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CANADA; CLINICAL TRIAL; EPIDEMIOLOGY; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE MALFORMATION SYNDROME; REGRESSION ANALYSIS; SEX RATIO;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLELES; ANALYSIS OF VARIANCE; APOLIPOPROTEINS A; DATA COLLECTION; ETHNIC GROUPS; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; QUEBEC; REGRESSION ANALYSIS; SAMPLING STUDIES; SEX DISTRIBUTION;

EID: 0030158937     PISSN: 00187143     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Brenninkmeijer, B J.P., P.M. Stuyt, P.N.M Demacker et al. 1987. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype J. Lipid Res. 28:361-370.
2. Brunzell, J.T. 1989. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In The Metabolic Basis of Inherited Disease, C.R. Scriver, A.L. Beaudet, W.S. Sly et al., eds. New York. McGraw-Hill, 1165-1180.
3. Charbonneau, H., B. Desjardins, A. Guillemette et al. 1987. Naissance d'une population: Les français établis au Canada au XVIIe siècle. Editions de l'Institut National d'Etudes Démographiques. Montréal, Canada: Presses de l'Université de Montréal and Presses Universitaires de France.
4. Dallongeville, J., S. Lussier-Cacan, and J. Davignon. 1992. Modulation of plasma triglyceride levels by apoE phenotype: A meta-analysis. J. Lipid Res. 33:447-454.
5. Das, H.K., J. McPherson, G.A.P. Bruns et al. 1985. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem. 260:6240-6247.
6. Davignon, J. 1993. Apolipoprotein E polymorphism and atherosclerosis. In New Horizons in Coronary Heart Disease, G.V.R. Born and C.J. Schwartz, eds. London, England: Science Press Ltd., 5.1-5.21.
7. Davignon, J , R.E. Gregg, and C.F. Sing. 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21.
8. DeBraekeleer, M., and T.-N. Dao. 1994a. Hereditary disorders in the French Canadian population of Quebec. I. Search of founders. Hum. Biol. 66:205-223.
9. DeBraekeleer, M., and T.-N. Dao. 1994b. Hereditary disorders in the French Canadian population of Quebec. II. Contribution of Perche. Hum. Biol. 66:225-249.
10. Ehnholm, C., R.W. Mahley, D.A. Chappell et al. 1984. Role of apolipoprotein E in the lipolytic conversion of β-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. Proc. Natl. Acad. Sci. USA 81:5566-5570.
11. Eichner, J.E., L.H. Kuller, R.E. Ferrell et al. 1990. Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the Healthy Women Study. Arteriosclerosis 10:379-385.
12. Friedewald, W.T., R.I. Levy, and D.S. Fredrickson. 1972. Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin. Chem. 18:499-502.
13. Gagné, C.L., S. Brun, S. Moorjani et al. 1989. Primary lipoprotein lipase activity: Clinical investigation of a French Canadian population. Can. Med. Assoc. J. 140:405-411.
14. Gerdes, L.U., I.C. Klausen, I. Sihm et al. 1992. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet. Epidemiol. 9:155-167.
15. Gregg, R.R., L.A. Zech, E.J. Schaefer et al. 1984. Apolipoprotein E metabolism in normolipoproteinemic human subjects. J. Lipid Res. 25:1167-1176.
16. Hallman, D.M., E. Boerwinkle, N. Saha et al. 1991. The apolipoprotein E polymorphism. A comparison of allele frequencies and effects in nine populations. Am. J. Hum. Genet. 49:338-349.
17. Hanis, C.L., D. Hewett-Emmett, T.C. Douglas et al. 1991. Effects of the apolipoprotein E polymorphism on levels of lipids, lipoproteins, and apolipoprotein s among Mexican-Americans in Starr County, Texas. Arterioscler. Thromb. 11:362-370.
18. Heyer, E., and M. Tremblay. 1995. Variability of the genetic contribution of Quebec population founders associated to some deleterious genes. Am. J. Hum. Genet. 56:970-978.
19. Hobbs, H.H., M.S. Brown, D.W. Russel et al. 1987. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. New Engl. J. Med. 317:734-737.
20. Kamboh, M.I., C.E. Aston, and R.F. Hamman. 1995. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis valley, Colorado. Atherosclerosis 112:145-159.
21. Kamboh, M.I., C.E. Aston, R.E. Ferrell et al. 1993. Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. Atherosclerosis 98:201-211.
22. Lin-Lee, Y.C., F.T. Kao, P. Cheung et al. 1985. Apolipoprotein E gene mapping and expression: Localization of the structural gene to human chromosome 19 and expression of ApoE mRNA in lipoprotein- and non-lipoprotein-producing tissues. Biochemistry 24:3751-3756.
23. Lussier-Cacan, S., M. Xhignesse, J.L. Desmarais et al 1991. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: Comparison with changes occurring during oral contraceptive therapy. Metabolism 40:849-854.
24. MacLean, D.R., A. Petrasovits, M. Margundkar et al. 1992. Canadian Heart Health Surveys: A profile of cardiovascular risk; survey methods and data analysis Can. Med. Assoc. J. 146:1969-1974.
25. Mahley, R.W. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-629.
26. Mailly, F., J. Davignon, and A.C. Nestruck. 1990. Analytic isoelectric focusing with immobilized pH gradients of human apolipoprotein E from very low density lipoproteins and total plasma. J. Lipid Res. 31:149-155.
27. Matthews, K.A., E. Meilahn, L H. Kuller et al. 1989. Menopause and risk factors for coronary heart disease. N. Engl. J. Med. 321:641-646
28. McConathy, W.J., and C.S. Wang. 1989. Inhibition of lipoprotein lipase by the receptor-binding domain of apolipoprotein E. FEBS Lett. 251:250-252.
29. Moorjani, S., J. Morissette, C. Laberge et al. 1987. Apo E polymorphism in Quebec population. Clin. Invest. Med. 10(4):B51.
30. Moorjani, S., M. Roy, C. Gagné et al. 1989. Homozygous familial hypercholesterolemia among French Canadians in Quebec Province. Arteriosclerosis 9:211-216.
31. Pouliot, M.C., J.P. Després, S. Moorjani et al. 1990. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women. J. Lipid Res. 31:1023-1029.
32. Reeder, B.A., A. Angel, M. Ledoux et al. 1992. Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Can. Med. Assoc. J. 146:2009-2019.
33. Reilly, S.L., R.E. Ferrell, B.A. Kokttke et al. 1991. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am. J. Hum. Genet. 49:1155-1166.
34. SPSS-X Users Guide, 3d ed. Chicago, EL: SPSS Inc., 1988.
35. Templeton, A.R. 1987. The general relationship between average effect and average excess. Genet Res. 49:69-70.
36. US Department of Health, Education, and Welfare. 1982. Lipid and Lipoprotein Analysis: Manual of Laboratory Operation. Lipid Research Clinics Program, DHEW publication 75-678 rev. Washington, DC: Government Printing Office.
37. Wang, C.S., W.J. McConathy, H.U. Kloer et al. 1985. Modulation of lipoprotein lipase activity by apolipoproteins. J. Clin. Invest. 75:384-390.
38. Xhignesse, M., S. Lussier-Cacan, C.F. Sing et al. 1991. Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler. Thromb. 11:1100-1110.
39. Xu, C.F., P.J. Talmud, F. Angelico et al. 1991. Apolipoprotein B polymorphism and plasma lipid, lipoprotein, and apolipoprotein levels in Italian children. Genet. Epidemiol. 8:389-398.
40. Yamada, N., and T. Murase. 1980. Modulation by apolipoprotein E of lipoprotein lipase activity. Biochem. Biophys. Res. Commun. 94:710-715.